
Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
The judges have spoken. Here are this year's winners.
Forty-eight entries. Two days of judging. Twelve winners. Here's a





